We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+15.74%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$308M
AUM Growth
+$41.5M
Cap. Flow
+$7.42M
Cap. Flow %
2.41%
Top 10 Hldgs %
61.93%
Holding
115
New
6
Increased
17
Reduced
6
Closed
10
Avg Time Held
2.2 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$9.26M
2
MPLX icon
MPLX
MPLX
+$4.48M
3
MIK
Michaels Stores, Inc
MIK
+$2.86M
4
CLMT icon
Calumet Specialty Products
CLMT
+$2.72M
5
INDP icon
Indaptus Therapeutics
INDP
+$1.21M

Top Sells

Rank Stock Value
1
OSG icon
Octave Specialty Group
OSG
+$2.89M
2
ONCT icon
Oncternal Therapeutics, Inc. Common Stock
ONCT
+$735K
3
UAL icon
United Airlines
UAL
+$697K
4
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
+$392K
5
ANCB
Anchor Bancorp
ANCB
+$321K

Sector Composition

Rank Sector Weight
1 Healthcare 48.43%
2 Technology 14.64%
3 Energy 8.34%
4 Industrials 6.41%
5 Financials 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LKQ icon
26
LKQ Corp
LKQ
$5.62B
$2.38M 0.77%
75,000
– –
2018 Q2
1 quarter
XENE icon
27
Xenon Pharmaceuticals
XENE
$3.24B
$2.29M 0.74%
173,390
– –
2017 Q3
4 quarters
CPRX icon
28
DELISTED
Catalyst Pharmaceutical
CPRX
$2.09M 0.68%
553,475
+40,000
+8% +$125K
2017 Q1
6 quarters
CHCT icon
29
Community Healthcare Trust
CHCT
$379M
$1.86M 0.6%
60,000
– –
2015 Q2
13 quarters
CXW icon
30
CoreCivic
CXW
$3.03B
$1.82M 0.59%
75,000
– –
2016 Q4
7 quarters
STML
31
DELISTED
Stemline Therapeutics, Inc.
STML
$1.75M 0.57%
105,287
+15,287
+17% +$245K
2017 Q1
6 quarters
ARNA
32
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.73M 0.56%
37,491
+2,800
+8% +$114K
2017 Q3
4 quarters
INDP icon
33
Indaptus Therapeutics
INDP
$350M
$1.6M 0.52%
+127
New +$1.21M
2018 Q3
0 quarters
AB icon
34
AllianceBernstein
AB
$3.21B
$1.54M 0.5%
50,500
– –
2013 Q2
21 quarters
HZNP
35
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.44M 0.47%
73,640
– –
2018 Q2
1 quarter
ZGNX
36
DELISTED
Zogenix, Inc.
ZGNX
$1.29M 0.42%
26,039
+4,039
+18% +$206K
2017 Q3
4 quarters
QTNT
37
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.26M 0.41%
4,175
– –
2017 Q4
3 quarters
EIGR
38
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.21M 0.39%
3,356
+297
+10% +$102K
2017 Q3
4 quarters
AIMT
39
DELISTED
Aimmune Therapeutics
AIMT
$1.2M 0.39%
44,152
+3,372
+8% +$95.4K
2017 Q3
4 quarters
RHP icon
40
Ryman Hospitality Properties
RHP
$8.69B
$1.07M 0.35%
12,400
– –
2013 Q2
21 quarters
CNQ icon
41
Canadian Natural Resources
CNQ
$111B
$1.06M 0.34%
66,059
– –
2017 Q2
5 quarters
BDSI
42
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.05M 0.34%
374,000
+166,000
+80% +$466K
2018 Q1
2 quarters
JNJ icon
43
Johnson & Johnson
JNJ
$616B
$1.01M 0.33%
7,280
– –
2013 Q2
21 quarters
CNCE
44
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$979K 0.32%
66,000
+14,443
+28% +$227K
2017 Q3
4 quarters
VZ icon
45
Verizon
VZ
$186B
$977K 0.32%
18,311
– –
2014 Q2
17 quarters
XLRN
46
DELISTED
Acceleron Pharma
XLRN
$939K 0.3%
16,400
– –
2018 Q2
1 quarter
XRN.PRA icon
47
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$76.6M
$879K 0.29%
35,000
– –
2017 Q3
4 quarters
T icon
48
AT&T
T
$161B
$741K 0.24%
29,194
– –
2014 Q2
17 quarters
SVC
49
Service Properties Trust
SVC
$796M
$721K 0.23%
5,000
– –
2015 Q1
14 quarters
CBAY icon
50
DELISTED
Cymabay Therapeutics
CBAY
$698K 0.23%
63,000
+43,000
+215% +$534K
2018 Q2
1 quarter
1
2
3 4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q3 2018 Portfolio in Review

As of Q3 2018, David M. Knott held 115 positions worth $308M, up 16% from $267M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

David M. Knott's Q3 2018 filing shows 6 new, 17 increased, 6 reduced and 10 closed positions. Its largest new stake was FTAI Aviation: 586,746 shares worth $9.11M. The largest sale was Octave Specialty Group, an estimated $2.89M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 44% a quarter earlier, followed by Technology and Energy.

  • David M. Knott's largest Q3 2018 buy was FTAI Aviation: 586,746 shares worth $9.11M.
  • David M. Knott added most to MPLX in Q3 2018, an estimated $4.48M increase.
  • David M. Knott's biggest Q3 2018 reduction was Macquarie Infrastructure Holdings, LLC, cutting an estimated $293K.
  • David M. Knott fully exited Octave Specialty Group in Q3 2018, selling an estimated $2.89M.
  • David M. Knott's ten largest holdings make up 62% of its $308M portfolio in Q3 2018.
  • David M. Knott opened 6 new positions and closed 10 in Q3 2018.
  • David M. Knott's portfolio value rose 16% quarter-over-quarter to $308M.

Based on David M. Knott's 13F filing for Q3 2018, filed 13 Nov 2018.